Rifampin Prophylaxis for Contacts of Haemophilus influenzae Type b Disease

Frederick Cox, Rose Trincher, J. Peter Rissing, Maurice Patton, George H. Mccracken, Dan M. Granoff

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Rifampin prophylaxis (20 mg/kg once daily for four days) was used in close contacts of children with Haemophilus influenzae type b (HIB) disease. Two hours after a dose, the concentration of rifampin in serum and saliva exceeded the minimum bactericidal concentrations of organisms obtained from four of the carriers. In both a randomized prospective and an open study, nasopharyngeal carriage was eradicated in 37 (95%) of 39 contacts. No cases of serious H influenzae disease occurred in four to six months of follow-up. At the dose and treatment schedule used, rifampin was safe and effective for eradication of HIB carriage. (JAMA 1981;245:1043-1045).

Original languageEnglish (US)
Pages (from-to)1043-1045
Number of pages3
JournalJAMA - Journal of the American Medical Association
Volume245
Issue number10
DOIs
StatePublished - Mar 13 1981

Fingerprint

Haemophilus influenzae type b
Rifampin
Saliva
Human Influenza
Appointments and Schedules
Prospective Studies
Serum
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rifampin Prophylaxis for Contacts of Haemophilus influenzae Type b Disease. / Cox, Frederick; Trincher, Rose; Rissing, J. Peter; Patton, Maurice; Mccracken, George H.; Granoff, Dan M.

In: JAMA - Journal of the American Medical Association, Vol. 245, No. 10, 13.03.1981, p. 1043-1045.

Research output: Contribution to journalArticle

Cox, Frederick ; Trincher, Rose ; Rissing, J. Peter ; Patton, Maurice ; Mccracken, George H. ; Granoff, Dan M. / Rifampin Prophylaxis for Contacts of Haemophilus influenzae Type b Disease. In: JAMA - Journal of the American Medical Association. 1981 ; Vol. 245, No. 10. pp. 1043-1045.
@article{b1ed4985cea448e9a2ef601bf21655c2,
title = "Rifampin Prophylaxis for Contacts of Haemophilus influenzae Type b Disease",
abstract = "Rifampin prophylaxis (20 mg/kg once daily for four days) was used in close contacts of children with Haemophilus influenzae type b (HIB) disease. Two hours after a dose, the concentration of rifampin in serum and saliva exceeded the minimum bactericidal concentrations of organisms obtained from four of the carriers. In both a randomized prospective and an open study, nasopharyngeal carriage was eradicated in 37 (95{\%}) of 39 contacts. No cases of serious H influenzae disease occurred in four to six months of follow-up. At the dose and treatment schedule used, rifampin was safe and effective for eradication of HIB carriage. (JAMA 1981;245:1043-1045).",
author = "Frederick Cox and Rose Trincher and Rissing, {J. Peter} and Maurice Patton and Mccracken, {George H.} and Granoff, {Dan M.}",
year = "1981",
month = "3",
day = "13",
doi = "10.1001/jama.1981.03310350031018",
language = "English (US)",
volume = "245",
pages = "1043--1045",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Rifampin Prophylaxis for Contacts of Haemophilus influenzae Type b Disease

AU - Cox, Frederick

AU - Trincher, Rose

AU - Rissing, J. Peter

AU - Patton, Maurice

AU - Mccracken, George H.

AU - Granoff, Dan M.

PY - 1981/3/13

Y1 - 1981/3/13

N2 - Rifampin prophylaxis (20 mg/kg once daily for four days) was used in close contacts of children with Haemophilus influenzae type b (HIB) disease. Two hours after a dose, the concentration of rifampin in serum and saliva exceeded the minimum bactericidal concentrations of organisms obtained from four of the carriers. In both a randomized prospective and an open study, nasopharyngeal carriage was eradicated in 37 (95%) of 39 contacts. No cases of serious H influenzae disease occurred in four to six months of follow-up. At the dose and treatment schedule used, rifampin was safe and effective for eradication of HIB carriage. (JAMA 1981;245:1043-1045).

AB - Rifampin prophylaxis (20 mg/kg once daily for four days) was used in close contacts of children with Haemophilus influenzae type b (HIB) disease. Two hours after a dose, the concentration of rifampin in serum and saliva exceeded the minimum bactericidal concentrations of organisms obtained from four of the carriers. In both a randomized prospective and an open study, nasopharyngeal carriage was eradicated in 37 (95%) of 39 contacts. No cases of serious H influenzae disease occurred in four to six months of follow-up. At the dose and treatment schedule used, rifampin was safe and effective for eradication of HIB carriage. (JAMA 1981;245:1043-1045).

UR - http://www.scopus.com/inward/record.url?scp=84944965146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944965146&partnerID=8YFLogxK

U2 - 10.1001/jama.1981.03310350031018

DO - 10.1001/jama.1981.03310350031018

M3 - Article

VL - 245

SP - 1043

EP - 1045

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 10

ER -